Generation Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Generation Bio generated cash of -$52,745,000, which is more than the previous year. Cash used in financing activities reached the amount of $35,817,000 last year. Net change in cash is therefore -$26,626,000.
Cash Flow
| 2018 | -28.11M | -69.76M | 100.18M |
|---|---|---|---|
| 2019 | -40.34M | 47.98M | 78K |
| 2020 | -70.14M | -205.19M | 323.09M |
| 2021 | -91.82M | 193.04M | 214.67M |
| 2022 | -102.44M | -192.51M | 12.98M |
| 2023 | -52.74M | -9.69M | 35.81M |
GBIO Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 98.86M | 380.83M | 64.94M | 17.18M | 9.46M | 7.15M |
Operating activities | ||||||
Net income | -126.61M | -136.63M | -119.15M | -80.52M | -61.31M | -35.80M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 5.26M | 5.13M | 4.53M | 3.43M | 1.86M | 347K |
Stock-based compensation expense | 24.34M | 24.45M | 17.85M | 8.41M | 4.20M | 0 |
| Deferred income tax benefit | 24.34M | 24.45M | 17.85M | 8.41M | 4.20M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | -395K | 0 | 448K | 840K | 0 |
Inventories | 0 | 395K | 0 | -448K | -840K | 0 |
Accounts payable | 1.08M | -1.38M | 1.75M | -1.44M | 761K | 223K |
Cash generated by operating activities | -52.74M | -102.44M | -91.82M | -70.14M | -40.34M | -28.11M |
Investing activities | ||||||
Purchases Of Investments | -405.30M | -323.71M | -105K | -243.17M | -20.78M | -109.94M |
Investments In Property Plant And Equipment | -7.39M | -8.80M | -5.95M | -5.51M | -19.98M | -3.02M |
Acquisitions Net | 0 | 183.71M | 105K | 199.67M | 80K | 0 |
Cash generated by investing activities | -9.69M | -192.51M | 193.04M | -205.19M | 47.98M | -69.76M |
Financing activities | ||||||
Common Stock Issued | 36M | 12.36M | 211.87M | 213.9M | 100K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 35.81M | 12.98M | 214.67M | 323.09M | 78K | 100.18M |
Net Change In Cash | -26.62M | -281.97M | 315.89M | 47.75M | 7.71M | 2.30M |
Cash at end of period | 72.23M | 98.86M | 380.83M | 64.94M | 17.18M | 9.46M |
| Data source | Data source | Data source | Data source |